Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [177Lu-[DOTA0, Tyr3]-octreotate
Abstract Background This study’s aim was to develop our dosimetric methodology using a commercial workstation for the routine evaluation of the organs at risk during peptide receptor radionuclide therapy (PRRT) with 177Lu. Methods First, planar and SPECT sensitivity factors were determined on phanto...
Main Authors: | Lore Santoro, Erick Mora-Ramirez, Dorian Trauchessec, Soufiane Chouaf, Pierre Eustache, Jean-Pierre Pouget, Pierre-Olivier Kotzki, Manuel Bardiès, Emmanuel Deshayes |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2018-11-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13550-018-0459-4 |
Similar Items
-
Cellular dosimetry of [177Lu]Lu-DOTA-[Tyr3]octreotate radionuclide therapy: the impact of modeling assumptions on the correlation with in vitro cytotoxicity
by: Giulia Tamborino, et al.
Published: (2020-02-01) -
Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of <sup>177</sup>Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells
by: Rashmi G. Shah, et al.
Published: (2021-01-01) -
Use of [177Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study
by: Matthew Glover, et al.
Published: (2021-11-01) -
Adenovirus Serotype 5 Vectors with Tyr3-Octreotate Modified as a Virulytic Oncotherapy Agent in AGS Cells
by: Najmeh Yarkeh Salkhori, et al.
Published: (2020-12-01) -
Dosimetric Evaluation of <sup>177</sup>Lu Peptide Receptor Radionuclide Therapy Using GATE and Planet Dose
by: Ioanna Stamouli, et al.
Published: (2023-08-01)